Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
0 competitors in Relapsing Remitting Multiple Sclerosis
View Full LandscapeTarget Indication
Relapsing Remitting Multiple Sclerosis
Clinical Trial
NCT01307332Last updated: 8/25/2026
No patent data available. Pre-approval drugs may not have Orange Book listings.
Morbid Obesity
Larynx Cancer
Brain Infarction
Osteoarthritis
Carcinoma, Non-Small-Cell Lung